NCT00574197View on ClinicalTrials.gov

Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients

PHASE4CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Gastrointestinal SymptomsHeart Transplantation

Interventions

DRUG

Mycophenolate Sodium

1440mg/day (720mg by mouth, twice a day)

Trial Locations (1)

90048

Cedars- Sinai Medical Center, Los Angeles

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Cedars-Sinai Medical Center

OTHER